92 results
8-K
EX-99.1
HUMA
Humacyte Inc
10 May 24
Humacyte First Quarter 2024 Financial Results and Business Update
7:06am
of 2023. The current-period increase resulted primarily from increased materials and personnel expenses to support expanded research and development
DEFA14A
HUMA
Humacyte Inc
29 Apr 24
Additional proxy soliciting materials
7:16am
Definitive Additional Materials
Soliciting Material Pursuant to §240.14a-12
Humacyte, Inc.
(Name of Registrant as Specified In Its Charter)
(Name … previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rule 14a-6(i)(1) and 0-11
8-K
EX-99.1
plj0n24
22 Mar 24
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update
7:06am
8-K
EX-1.1
tqd 9vlry
4 Mar 24
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
6:53am
424B5
cr6 8lbsauqu1yyt
1 Mar 24
Prospectus supplement for primary offering
4:05pm
424B5
u1qw9 44ud
29 Feb 24
Prospectus supplement for primary offering
4:11pm
424B3
xbcgyq 5q
22 Jun 23
Prospectus supplement
6:50am
DEFA14A
fzmz7ja
28 Apr 23
Additional proxy soliciting materials
6:46am
424B3
ugh6p yw8vifrlikq0
9 Sep 22
Prospectus supplement
4:43pm